3XZ-17838-35735
2 vaccinations
3 coded responses
16 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 301 / GA
- Registered
- 2022-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-01-05
Registered in v-safe
-
2022-01-05
Dose 1 — Pfizer-BioNTech
- 2022-01-05
-
2022-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-01-10
- 2022-01-11
- 2022-01-19
-
2022-01-26
Dose 2 — Pfizer-BioNTech
- 2022-01-26
-
2022-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-29
- 2022-01-30
-
2022-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: Fair · Fatigue or tirednessFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-02-01
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Sore throat, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-02-02
Survey response — day 7, dose 2MedDRA: Respiratory tract congestion — Feeling: Fair · Headache, Fatigue or tirednessFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
- 2022-02-09
- 2022-02-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-05 | Pfizer-BioNTech | No |
| 2 | 2022-01-26 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat
Systemic reaction (other): Sore throat, congestion
Release 11 — day 7, dose 2
Systemic reaction (other): Congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release